Study discovers which liver tumours with β-catenin mutations respond to immunotherapy
An international study led by the University of Edinburgh, with the participation of the IDIBAPS Translational Research in Hepatic Oncology group,...
An international study led by the University of Edinburgh, with the participation of the IDIBAPS Translational Research in Hepatic Oncology group,...
Eight researchers from Clínic-IDIBAPS and the University of Barcelona have been recognized as Highly Cited Researchers by Clarivate Analytics, a di...
Researchers from Clínic-IDIBAPS have participated in a Lancet Commission with international experts highlighting that more than 60% of liver cancer...
The European Society for Medical Oncology (ESMO) has published a new clinical practice guideline for the diagnosis, treatment, and follow-up of hep...
The Scientific Foundation of the Spanish Association Against Cancer has created its own research centre accreditation system to ‘promote excellence...
The Journal of Hepatology has published a study led by Josep M Llovet’s team at IDIBAPS-Hospital Clínic identifying the molecular characteristics a...
On Thursday 13 March 2025, IDIBAPS held the first meeting of the new research project ‘AECC-IDIBAPS Excellence Programme: Immunotherapy Against Can...
Funded by the Spanish Association Against Cancer (AECC) and coordinated by IDIBAPS and the Salamanca Cancer Research Centre, ASPIRE-AECC aims to im...
On Monday 24 February, the Spanish Association Against Cancer (AECC) held a ceremony to announce the research grants awarded in Barcelona during 20...
A new study published in the journal Nature, with the participation of Josep M Llovet and four members of his team at Hospital Clínic-IDIBAPS, desc...